午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11974
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
Felzartamab 2197112-39-1
CCCI-01 215778-97-5
Zanidatamab 2169946-15-8
Amivantamab 2171511-58-1
Axatilimab 2155851-88-8
Zelminemab 2225850-33-7
Glucocorticoid receptor agonist-1 2166375-82-0
Nec-34i 2212541-00-7
RO7185876 2226038-71-5
IRAK4-IN-21 2170694-04-7
Tau-aggregation and neuroinflammation-IN-1 2175953-98-5
(S)-Desmethyl-NNC112 221132-62-3
2'-O-(2-Azidoethyl)adenosine 2226475-42-7
Relfovetmab 2171034-70-9
Disitamab 2185868-98-6
Sasanlimab 2206792-50-7
Tinurilimab 2226224-30-0
MI-389 2222635-92-7
Ruplizumab 220651-94-5
LTβR-IN-1 2189366-77-4
Nidanilimab 2171061-85-9
Cosibelimab 2216751-26-5
MY33-3 2204280-41-9
AZD8154 2215022-45-8
(S,R,S)-AHPC-CO-C9-acid 2172819-78-0
Zagociguat 2201048-82-8
ATG7-IN-2 2226227-75-2
Metronidazole-hydroxy-d2 2196180-19-3
AKOS037652256 2171065-77-1
Lacutamab 2187368-16-5
Batoclimab 2187430-05-1
PSMA I&T 2192281-54-0
NV-5440 2226614-88-4
MY10 2204270-73-3
Tuberculosis inhibitor 3 2219325-28-5
K-111 221564-97-2
Ragifilimab 2207590-51-8
(S)-HH2853 2202678-05-3
Benproperine 2156-27-6
Chst15-IN-1 2158198-77-5
Garadacimab 2162134-62-3
Avdoralimab 2226393-85-5
Nurulimab 2168561-20-2
Crobenetine 221019-25-6
L 756423 216863-66-0
Indole-C2-amide-C2-NH2 215789-29-0
SOCE inhibitor 1 2169316-15-6
Semorinemab 2159141-27-0
Dovanvetmab 2171034-71-0
Tafolecimab 2225109-03-3
Thalidomide-O-C6-COOH 2169266-69-5
DBCO-PEG3-NHS ester 2163772-16-3
Propionanilide, 3'-hydroxy- 21556-86-5
Astegolimab 2173054-79-8
SCH 57790 221660-80-6
L-796,778 217480-25-6
ALDH1A2-IN-1 2204229-64-9
(R)-HH2853 2202678-06-4
PARP10-IN-3 2225800-19-9
Labetuzumab 219649-07-7
Lenalidomide-PEG1-azide 2185795-67-7
Magrolimab 2169232-81-7
Manelimab 2168561-26-8
Atinvicitinib 2169273-59-8
IRAK4-IN-22 2170694-05-8
Bamocaftor 2204245-48-5
Simazine-d5 220621-41-0
TLR7 agonist 1 2178156-33-5
Bedinvetmab 2171034-69-6
Encelimab 2173096-82-5
TLR7/8-IN-1 2205095-75-4
Elsibucol 216167-95-2
Pramiconazole 219923-85-0
Sonlicromanol hydrochloride 2162149-24-6
KDM2A/7A-IN-1 2169272-46-0
IL-17A antagonist 1 2205034-18-8
Petosemtamab 2213450-26-9
Talquetamab 2226212-40-2
AVG-233 2151937-80-1
(R)-GSK-3685032 2170140-50-6
Cytembena 21739-91-3
Arg-Gly-Asp-Cys TFA 2171504-22-4
Mitumomab 216503-58-1
4,4-Diphenylbutylamine hydrochloride 22101-90-2
Benzyl-PEG12-alcohol 2218463-17-1
Gemnelatinib 2225123-30-6
Visilizumab 219716-33-3
Monuron-d6 217488-65-8
MY33-3 hydrochloride 2204280-42-0
Navocaftor 2159103-66-7
RO0270608 220846-33-3
SHP2-IN-6 hydrochloride 2169223-49-6
Sibrotuzumab 216669-97-5
MMV688845 2208962-35-8
Mal-amide-PEG8-Val-Ala-PAB-PNP 2210247-59-7
Befovacimab 2156634-62-5
SARS-CoV-2-IN-14 22203-98-1
Pexelizumab 219685-93-5
INCB-000928 2173389-57-4
TZ3O 2218754-19-7
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.